Literature DB >> 23990495

The influence of expertise of the surgical pathologist to undergrading, upgrading, and understaging of prostate cancer in patients undergoing subsequent radical prostatectomy.

Attila Majoros1, Attila Marcell Szász, Péter Nyirády, Eszter Székely, Péter Riesz, Attila Szendrői, Attila Keszthelyi, Janina Kulka, Imre Romics.   

Abstract

PURPOSE: The main objective of this retrospective study was to evaluate the influence of pathological experience in histological examination of prostate cancer (PCa) on preoperative understaging (UNS), undergrading (UNG), and upgrading (UPG).
METHODS: Histopathological data of prostate biopsy (PB) and radical prostatectomy (RP) specimens of patients undergoing subsequent radical prostatectomy (n = 430) in our center were compared. Histological diagnoses of PB were provided either by corresponding academic pathology institute (Group 1: 322 patients) or by external (nonacademic) departments which had a lower number (≤ 100/year) of PCa histopathological evaluations (Group 2 108 patients). The rate of UNG, UPG, and UNS in both groups and also the effects of institutional learning curve were analyzed in terms of grading and staging.
RESULTS: Significant difference was detected between Group 1 and Group 2 in average preoperative Gleason score (GS) values and in the rate of well, moderately, and poorly differentiated cancers as well. There was also a significant difference in the rate of UNG (29.1 vs. 56.5 %, p < 0.0001). The mean preoperative and postoperative GS in Group 1 was significantly lower in the first 50 than in the last 50 patients, but the rates of UNG, UPG, and UNS did not differ significantly between the groups.
CONCLUSIONS: The experience of pathologists has direct influence on grading concordance and on UNG and UPG, between PB and RP specimen; however, it has no significant effect on complete preoperative understaging. The bigger pathological experience improves the sensitivity of the histological diagnostic process.

Entities:  

Mesh:

Year:  2013        PMID: 23990495     DOI: 10.1007/s11255-013-0538-4

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  21 in total

1.  The value of mandatory second opinion pathology review of prostate needle biopsy interpretation before radical prostatectomy.

Authors:  Fadi Brimo; Luciana Schultz; Jonathan I Epstein
Journal:  J Urol       Date:  2010-05-15       Impact factor: 7.450

2.  Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.

Authors:  Felix K-H Chun; Thomas Steuber; Andreas Erbersdobler; Eike Currlin; Jochen Walz; Thorsten Schlomm; Alexander Haese; Hans Heinzer; Michael McCormack; Hartwig Huland; Markus Graefen; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2005-12-22       Impact factor: 20.096

Review 3.  Undergrading of prostate cancer biopsies: a paradox inherent in all biologic bivariate distributions.

Authors:  D F Gleason
Journal:  Urology       Date:  1996-03       Impact factor: 2.649

4.  Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome.

Authors:  Jehonathan H Pinthus; Maciej Witkos; N E Fleshner; Joan Sweet; Andrew Evans; M A Jewett; Murray Krahn; Shabir Alibhai; John Trachtenberg
Journal:  J Urol       Date:  2006-09       Impact factor: 7.450

5.  Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies.

Authors:  D G Bostwick
Journal:  Am J Surg Pathol       Date:  1994-08       Impact factor: 6.394

6.  [Optimized standards for prostate biopsy].

Authors:  B Wullich; S Füssel; R Grobholz
Journal:  Urologe A       Date:  2007-06       Impact factor: 0.639

7.  Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer.

Authors:  Ayman S Moussa; Jianbo Li; Meghan Soriano; Eric A Klein; Fei Dong; J Stephen Jones
Journal:  BJU Int       Date:  2008-09-08       Impact factor: 5.588

8.  Role of prostate biopsy schemes in accurate prediction of Gleason scores.

Authors:  Badar M Mian; David J Lehr; Courtenay K Moore; Hugh A G Fisher; Ronald P Kaufman; Jeffery S Ross; Timothy A Jennings; Tipu Nazeer
Journal:  Urology       Date:  2006-02       Impact factor: 2.649

Review 9.  Optimal biopsy strategies for the diagnosis and staging of prostate cancer.

Authors:  Amit R Patel; J Stephen Jones
Journal:  Curr Opin Urol       Date:  2009-05       Impact factor: 2.309

10.  A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer.

Authors:  A V D'Amico; R Whittington; S B Malkowicz; D Schultz; M Schnall; J E Tomaszewski; A Wein
Journal:  J Urol       Date:  1995-07       Impact factor: 7.450

View more
  4 in total

Review 1.  Developing a National Center of Excellence for Prostate Imaging.

Authors:  Annerleim Walton-Diaz; Manuel Madariaga-Venegas; Nicolas Aviles; Juan Carlos Roman; Ivan Gallegos; Mauricio Burotto
Journal:  Curr Urol Rep       Date:  2019-09-02       Impact factor: 3.092

2.  Gleason grading challenges in the diagnosis of prostate adenocarcinoma: experience of a single institution.

Authors:  Sonja D Chen; Joseph L Fava; Ali Amin
Journal:  Virchows Arch       Date:  2015-11-12       Impact factor: 4.064

3.  Pathological upgrading and upstaging at radical prostatectomy in Jamaican men with low-risk prostate cancer.

Authors:  Belinda F Morrison; William D Aiken; Gareth Reid; Richard Mayhew; Barrie Hanchard
Journal:  Ecancermedicalscience       Date:  2019-10-29

4.  Low-risk prostate cancer in India: Is active surveillance a valid treatment option?

Authors:  Shanky Singh; Saurabh Patil; Ashwin Sunil Tamhankar; Puneet Ahluwalia; Gagan Gautam
Journal:  Indian J Urol       Date:  2020-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.